Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Recabrio
Synonyms :
Imipenem/ cilastatin /relebactam
Class :
Carbapenems/beta-lactamase inhibitors
Brand Name :
Recabrio
Synonyms :
Imipenem/ cilastatin /relebactam
Class :
Carbapenems/beta-lactamase inhibitors
Dosage Forms & StrengthsÂ
Injection, powder for reconstitutionÂ
500mg/500mg/250mg per vialÂ
1.25
g
Solution
Injection
every 6 hours
4 - 14
days
1.25
g
Solution
Injection
every 6 hours
4 - 14
days
1.25
g
Solution
Injection
every 6 hours
4 - 14
days
Dose Adjustments
CrCl <15 ml/min: Do not use until haemodialysis is initiated
CrCl 15-29 ml/min:0.5g IV every 6 hours
CrCl 30-59 ml/min:0.75g IV every 6 hours
CrCl 60-89 ml/min:1g IV every 6 hours
Dosage Forms & StrengthsÂ
<18 years: Safety and efficacy not establishedÂ
<18 years: Safety and efficacy not established
may decrease the therapeutic effect of antibiotics
may decrease the therapeutic effect of antibiotics
may decrease the therapeutic effect of antibiotics
may increase the neurotoxic effects of imipenem
may decrease the therapeutic effect of antibiotics
may decrease the therapeutic effect of antibiotics
may decrease the therapeutic effect of antibiotics
may decrease the therapeutic effect of antibiotics
Frequency defined:Â Â
1-10%Â
NauseaÂ
VomitingÂ
PhlebitisÂ
Increased lipaseÂ
DiarrheaÂ
HeadacheÂ
Increased ALTÂ
PyrexiaÂ
AnemiaÂ
CNS adverse effectsÂ
<1%Â
Increased blood creatinineÂ
Pregnancy consideration:Â
US FDA: Not assignedÂ
Lactation: Excretion of the drug in human breast milk is unknownÂ
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Patient information leafletÂ
Generic Name: Imipenem/ cilastatin /relebactamÂ
Pronounced: (IM-i-PEN-em, SYE-la-STAT-in, REL-e-BAK-tam)Â
Why do we use Imipenem/ cilastatin /relebactam?Â
It is used to treat complicated bacterial infections in the stomach and urinary tractÂ
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
